CR20150666A - Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético - Google Patents

Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético

Info

Publication number
CR20150666A
CR20150666A CR20150666A CR20150666A CR20150666A CR 20150666 A CR20150666 A CR 20150666A CR 20150666 A CR20150666 A CR 20150666A CR 20150666 A CR20150666 A CR 20150666A CR 20150666 A CR20150666 A CR 20150666A
Authority
CR
Costa Rica
Prior art keywords
pharmacocinetic
analgesics
profile
different
pharmaceutical composition
Prior art date
Application number
CR20150666A
Other languages
English (en)
Inventor
Suárez Graciela De Los Ángeles Aguilera
Lora Martha Rosaura Juárez
Sánchez Carmen Miguel Gómez
Original Assignee
Farmacêuticos Rayere S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20150666(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmacêuticos Rayere S A filed Critical Farmacêuticos Rayere S A
Publication of CR20150666A publication Critical patent/CR20150666A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas que contienen dos principios activos siendo uno de ellos un analgésico antiinflamatorio no esteroideo conocido como meloxicam o una de sus sales farmacéuticamente aceptables y el otro un analgésico antiinflamatorio no esteroideo conocido como clonixinato de lisina.
CR20150666A 2013-05-27 2015-12-17 Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético CR20150666A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2013/000070 WO2014193210A1 (es) 2013-05-27 2013-05-27 Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético

Publications (1)

Publication Number Publication Date
CR20150666A true CR20150666A (es) 2016-03-03

Family

ID=51989148

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150666A CR20150666A (es) 2013-05-27 2015-12-17 Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético

Country Status (6)

Country Link
EP (1) EP3025717B1 (es)
BR (1) BR112015024314A2 (es)
CR (1) CR20150666A (es)
ES (1) ES2586607B1 (es)
MX (1) MX351622B (es)
WO (1) WO2014193210A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262967B1 (es) * 1974-03-07 1977-11-04 Roemmers Sa Ind Comercial
DE4037554A1 (de) * 1990-11-26 1992-05-27 Roemmers Sa Arzneimittel zur topischen anwendung
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
WO2007083985A1 (es) * 2006-01-19 2007-07-26 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de diclofenaco y clonixinato de lisina
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
WO2007148950A1 (es) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina
MX357376B (es) * 2011-06-22 2018-07-06 Laboratorios Senosiain S A De C V Star Composicion farmaceutica para uso en inflamacion y dolor.

Also Published As

Publication number Publication date
ES2586607B1 (es) 2017-07-20
EP3025717B1 (en) 2018-11-07
MX351622B (es) 2017-10-17
MX2014004492A (es) 2016-03-15
BR112015024314A2 (pt) 2017-07-18
ES2586607A1 (es) 2016-10-17
WO2014193210A1 (es) 2014-12-04
EP3025717A1 (en) 2016-06-01
EP3025717A4 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
CU20160006A7 (es) Derivados de piperidinil-indol como inhibidores de factor de complemento b
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
NZ760790A (en) Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
CR20140508A (es) Moduladores de la ruta del complemento y usos de los mismos
GT201400261A (es) Solicitud pct face nacional novedosas n-piridinil amidas ciclicas sustituidas como inhibidores de quinasa
BR112015011430A2 (pt) composição para liberação imediata e prolongada
CY1122113T1 (el) Φαρμακευτικες συνθεσεις για τη θεραπεια του ελικοβακτηριδιου του πυλωρου
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
UY35209A (es) Compuestos tricíclicos
UY35211A (es) Compuestos tricíclicos
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
MX2015012318A (es) Formas de estado solido de un derivado de quinazolina y su uso como un inhibidor de braf.
CR20150275A (es) Composición de difenidol de liberación prolongada
BR112016005361B8 (pt) Composto, composição, e, uso de um composto
ECSP15050273A (es) Formulación oral para el tratamiento de enfermedades cardiovasculares
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
CL2015002188A1 (es) Agentes analgésicos oculares tópicos
BR112014022687A8 (pt) uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo
CR20150666A (es) Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
PE20150022A1 (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
CL2015003409A1 (es) Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético